Chronic administration of chlorothiazide and other thiazide analogues in diabetes insipidus results in a striking reduction in urinary volume with increase in urinary osmolality. This curious antidiuretic action was first described by Crawford & Kennedy (1959) , and though it has since been widely confirmed in both the pituitary and nephrogenic forms of the disease, its precise mechanism remains obscure. A number of investigators have sought to explain the phenomenon entirely on the basis of the renal actions of these drugs (Earley & Orloff 1962 , Goodman & Carter 1962 , whilst others have contended that abatement of polyuria may be secondary to a central effect of the thiazides in decreasing thirst (Robson & Lambie 1962 , Skadhauge 1963 .
Over the past two years, we have conducted detailed in-patient studies of the action of various diuretic drugs of the thiazide and other series in a group of 7 patients with pituitary diabetes insipidus.
The responses to randomized doses of diuretic have been measured adopting a standard method. The different compounds under study were administered for periods of three consecutive days, allowing at least three drug-free days before each period of diuretic therapy. Patients were maintained on a diet containing 80 mEq sodium per day; fluid intake, though carefully recorded, was unrestricted.
Hydroflumethiazide was used as a typical representative of the thiazide diuretics. Its antidiuretic activity was compared with that of triamterene, clorexolone and frusemide.
In none of the patients did triamterene display any antidiuretic activity. By contrast with hydroflumethiazide it produced only a slight increase in Clorexolone, like chlorthalidone, is a phthalimidine compound bearing close pharmacological resemblance to the thiazides except for a more prolonged diuretic action (36-48 hours) in states of chronic fluid retention. In our patients with diabetes insipidus, clorexolone produced a prompt and striking antidiuretic response which, unlike that of hydroflumethiazide, persisted for several days after withdrawal of the drug (Fig 2) .
Frusemide is a recently introduced potent diuretic whose action is complete by six hours after oral administration. Although we observed a significant decrease in urinary volume in diabetes insipidus after frusemide, the extent of antidiuresis was not as marked as after hydroflumethiazide or clorexolone (Fig 3) . In the case of all three diuretics, however, antidiuresis was associated with substantial increases in urinary (Figs 2 and 3) . In order to throw further light on the possible link between the renal actions and antidiuretic properties of these various diuretics, their acute effects on urine composition and concentration in diabetes insipidus were also investigated.
It is well established that in situations of high urine flow, thiazides increase the ratio of solute to water excreted by the kidney. They achieve this by inhibiting the selective reabsorption of sodium without water in the distal portion of the nephron and thus decrease the amount of solutefree water destined for excretion. In our patients, an acute reduction in the clearance of solute-free water (CH2o) occurred within the first four hours after oral administration of hydroflumethiazide and clorexolone. On the other hand, CH20 was not reduced during this period by either triamterene or frusemide. Urinary output of sodium was increased by all four drugs though its extent, in the case of triamterene, was only slight.
Our findings support the view that antidiuresis in diabetes insipidus is not a property exclusive to thiazide diuretics but may be produced by other powerful natriuretic agents. The occurrence of rapid and prominent antidiuresis after administration of a diuretic appears to demand a renal action of the compound in question predominantly upon the distal nephron where sodium is normally reabsorbed without water. According to this premise, triamterene fails as an antidiuretic in view of both its weak natriuretic activity and lack of influence on the renal clearance of free water. Potent natriuretics such as frusemide, whose major effects are not exerted upon the distal nephron, may nevertheless cause some antidiuresis. This may in part be attributable to the mild depletion of body sodium they induce and thereby simulates the antidiuretic response observed in diabetes insipidus after simple restriction of dietary intake of sodium.
The prompt yet sustained antidiuresis occurring after clorexolone is a feature of particular value in the chronic management of patients with diabetes insipidus. In our experience, satisfactory long-term control of polyuria and polydipsia has been maintained in the absence of any electrolyte imbalance by use of clorexolone in a dose of 12-5 mg twice daily with additional potassium supplements (40 mEq per day).
